Riccardo Villari Selected Research

Riccardo Villari Research Topics

9	COVID-19 04/2023 - 01/2022
3	Infections 05/2023 - 07/2022
3	Communicable Diseases (Infectious Diseases) 02/2023 - 07/2022
2	Disease Progression 01/2023 - 11/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Lymphopenia (Lymphocytopenia) 01/2023
1	Invasive Fungal Infections 01/2023
1	Coinfection 01/2023
1	Chronic Renal Insufficiency 11/2022
1	Heart Diseases (Heart Disease) 10/2022
1	Neoplasms (Cancer) 10/2022
1	Multiple Sclerosis 07/2022

5	Monoclonal AntibodiesIBA 04/2023 - 07/2022
4	Antiviral Agents (Antivirals)IBA 05/2023 - 01/2023
2	casirivimab and imdevimab drug combinationIBA 04/2023 - 02/2023
2	remdesivirIBA 02/2023 - 01/2023
1	imdevimabIBA 04/2023
1	SteroidsIBA 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 11/2022
1	molnupiravirIBA 10/2022
1	nirmatrelvir and ritonavir drug combinationIBA 10/2022
1	AntigensIBA 07/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	MTOR InhibitorsIBA 01/2022
1	sotrovimabIBA 01/2022

5	Therapeutics 04/2023 - 01/2023
1	Intravenous Infusions 04/2023
1	Critical Care (Surgical Intensive Care) 01/2023
1	Operative Time 10/2022